Literature DB >> 16676584

[Quantitative analysis of factors affected mortality trend in Chinese, 2002].

Gong-Huan Yang1, Jun-Fang Wang, Xia Wan, Li-Jun Wang, Ai-Ping Chen.   

Abstract

OBJECTIVE: To explain trend of death in Chinese by quantitative analysis of demographic and non-demographic factors and estimate the proportion of contribution of non-demographic and demographic factors.
METHODS: Using census data and death causes data of National Disease Surveillance Points at 1991 and 2000 to calculate the proportion of contribution of demographic and non-demographic factors and to change on various death causes from 1991 to 2000 by methods of decomposing the differences of death rates.
RESULTS: The death rate showed a rapid decrease during 1950 - 1975, mainly owing to the contribution of non-demographic factors, including economic development, popularization of education and health service, especially the "patriotic hygiene movement". During 1991 - 2000, the death causes of lung cancer, liver cancer, breast cancer, chronic heart disease, stroke, diabetes and traffic accident had been increasing. The increase of deaths caused by these diseases were contributed to the non-demographic factors including 63% of the increase on lung cancer and 88% of increase on death rate of traffic accidents.
CONCLUSION: The study showed that the risk factors had contributed to the increase of death rates, including behavioral risk factors described in the preceding 5 papers as smoking and passive smoking, unhealthy diet, sedentary life style, violating traffic regulation etc. In order to reduce the death rates on cancer, heart diseases, diabetes, traffic accidents, emphasis should be also laid on the change of unhealthy behaviors.

Entities:  

Mesh:

Year:  2005        PMID: 16676584

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  7 in total

1.  Estrogen upregulates the IGF-1 signaling pathway in lung cancer through estrogen receptor-β.

Authors:  Hexiao Tang; Yongde Liao; Guang Chen; Liqiang Xu; Chao Zhang; Sheng Ju; Sheng Zhou
Journal:  Med Oncol       Date:  2012-03-17       Impact factor: 3.064

2.  Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancer.

Authors:  Jing Deng; Wei Jia Fang; Xiao Chen Zhang; Dong Ping Wu; Hong Ming Fang; Jing Chen; Jiong Qian; Hai Bo Mou; Bin Bin Chu; Nong Xu; Li Song Teng
Journal:  Med Oncol       Date:  2011-03-12       Impact factor: 3.064

Review 3.  Burden of gastrointestinal cancer in Asia; an overview.

Authors:  Mohamad Amin Pourhoseingholi; Mohsen Vahedi; Ahmad Reza Baghestani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

4.  Lung cancer mortality clusters in Shandong Province, China: how do they change over 40 years?

Authors:  Zhentao Fu; Yingmei Li; Zilong Lu; Jie Chu; Jiandong Sun; Jiyu Zhang; Gaohui Zhang; Fuzhong Xue; Xiaolei Guo; Aiqiang Xu
Journal:  Oncotarget       Date:  2017-09-21

Review 5.  [Gender-associated differences of lung cancer and mechanism].

Authors:  Xin Xing; Yongde Liao; Hexiao Tang; Guang Chen; Sheng Ju; Liangkun You
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-07

6.  Decomposing contribution of age and non-age factors to rapid growth of lung cancer in Xuanwei over past 30 years.

Authors:  Yang Chen; Yize Xiao; Yongfang Yang; Jing Duan; Wen Xu
Journal:  BMC Public Health       Date:  2015-11-12       Impact factor: 3.295

7.  Changing pattern of premature mortality burden over 6 years of rapid growth of the economy in suburban south-west China: 1998-2003.

Authors:  Le Cai; Virasakdi Chongsuvivatwong; Alan Geater
Journal:  Public Health       Date:  2008-04-02       Impact factor: 2.427

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.